Cancer-targeting mechanism under development

Researchers are developing molecules that bind to more than 60 types of cancer. Several are being tested in early-stage clinical trials, including one for brain cancer. These custom-made molecules can carry either a „flag“ that shines brightly in standard medical scanners or a bit of radiation to kill the targeted cancer cells. (Mehr in: Cancer News — ScienceDaily)